S&P 500
(0.25%) 5 261.74 points
Dow J
(0.20%) 39 840 points
Nasdaq
(0.06%) 16 409 points
Oil
(2.08%) $83.04
Gas
(1.63%) $1.746
Gold
(1.26%) $2 240.50
Silver
(0.81%) $24.95
Platinum
(1.34%) $921.85
USD/EUR
(0.40%) $0.927
USD/NOK
(0.80%) $10.85
USD/GBP
(0.14%) $0.792
USD/RUB
(0.19%) $92.62

Realtime updates for Q BioMed Inc. [QBIO]

Exchange: PNK Industry: Biotechnology
Last Updated21 Mar 2024 @ 12:06

0.00% $ 0.000300

Live Chart Being Loaded With Signals

Commentary (21 Mar 2024 @ 12:06):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies...

Stats
Today's Volume 1 132.00
Average Volume 60 601.00
Market Cap 43 528.00
EPS $0 ( 2024-03-13 )
Next earnings date ( $0 ) 2024-05-26
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0100
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2022-05-26 Corin Denis Buy 200 000 Common Stock
2021-02-01 Rosenstadt William S Buy 35 000 Common stock
2020-10-27 Corin Denis Buy 500 000 Incentive Stock Options
2020-08-29 Corin Denis Buy 150 000 Incentive Stock Options
2020-08-29 Corin Denis Buy 150 000 Incentive Stock Options
INSIDER POWER
100.00
Last 100 transactions
Buy: 7 488 702 | Sell: 150 251

Q BioMed Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Q BioMed Inc. Financials

Annual 2022
Revenue: $284 352
Gross Profit: $-8 988.00 (-3.16 %)
EPS: $-0.0164
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0
Q1 2023
Revenue: $2 500.00
Gross Profit: $0 (0.00 %)
EPS: $-0.00760

Financial Reports:

No articles found.

Q BioMed Inc.

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators